EE200100575A - Seentevastased eetrid, nende valmistamismeetod jakasutamine, kompositsioon ja selle valmistamismeetod - Google Patents

Seentevastased eetrid, nende valmistamismeetod jakasutamine, kompositsioon ja selle valmistamismeetod

Info

Publication number
EE200100575A
EE200100575A EEP200100575A EEP200100575A EE200100575A EE 200100575 A EE200100575 A EE 200100575A EE P200100575 A EEP200100575 A EE P200100575A EE P200100575 A EEP200100575 A EE P200100575A EE 200100575 A EE200100575 A EE 200100575A
Authority
EE
Estonia
Prior art keywords
preparation
optionally substituted
aryl
6alkyl
naphthalenyl
Prior art date
Application number
EEP200100575A
Other languages
English (en)
Estonian (et)
Inventor
Jacobus Jozef Backx Leo
Meerpoel Lieven
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of EE200100575A publication Critical patent/EE200100575A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
EEP200100575A 1999-05-04 2000-04-20 Seentevastased eetrid, nende valmistamismeetod jakasutamine, kompositsioon ja selle valmistamismeetod EE200100575A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13269999P 1999-05-04 1999-05-04
PCT/EP2000/003740 WO2000066580A2 (en) 1999-05-04 2000-04-20 Antifungal ethers

Publications (1)

Publication Number Publication Date
EE200100575A true EE200100575A (et) 2003-02-17

Family

ID=22455197

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100575A EE200100575A (et) 1999-05-04 2000-04-20 Seentevastased eetrid, nende valmistamismeetod jakasutamine, kompositsioon ja selle valmistamismeetod

Country Status (27)

Country Link
US (1) US6583136B1 (de)
EP (1) EP1177192B1 (de)
JP (1) JP4610744B2 (de)
KR (1) KR20010094761A (de)
CN (1) CN1349540A (de)
AT (1) ATE234833T1 (de)
AU (1) AU768491B2 (de)
BG (1) BG105863A (de)
BR (1) BR0010279A (de)
CA (1) CA2372691C (de)
CZ (1) CZ20013866A3 (de)
DE (1) DE60001734T2 (de)
EA (1) EA200101172A1 (de)
EE (1) EE200100575A (de)
ES (1) ES2194723T3 (de)
HR (1) HRP20010763A2 (de)
HU (1) HUP0200872A3 (de)
ID (1) ID30409A (de)
IL (1) IL146302A0 (de)
MX (1) MXPA01011117A (de)
NO (1) NO20015372L (de)
NZ (1) NZ515118A (de)
PL (1) PL351749A1 (de)
SK (1) SK15772001A3 (de)
TR (1) TR200103212T2 (de)
WO (1) WO2000066580A2 (de)
ZA (1) ZA200109045B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2282463C1 (ru) * 2005-11-07 2006-08-27 Сергей Алексеевич Балехов Способ изготовления дезинфицирующего средства
JP6681894B2 (ja) * 2014-11-21 2020-04-15 エフツージー リミテッド 抗真菌剤
GB201609222D0 (en) 2016-05-25 2016-07-06 F2G Ltd Pharmaceutical formulation
US11819503B2 (en) 2019-04-23 2023-11-21 F2G Ltd Method of treating coccidioides infection
CN111138421A (zh) * 2019-12-26 2020-05-12 上海英诺富成生物科技有限公司 抗真菌水溶性化合物及其制备方法与应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3459731A (en) 1966-12-16 1969-08-05 Corn Products Co Cyclodextrin polyethers and their production
US4267179A (en) 1978-06-23 1981-05-12 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
US4619931A (en) 1983-02-28 1986-10-28 Janssen Pharmaceutica, N.V. [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles
CA1292472C (en) * 1985-12-03 1991-11-26 Alfonsus Guilielmus Knaeps Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles
US4791111A (en) 1985-12-23 1988-12-13 Janssen Pharmaceutica, N.V. [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles having anti-microbial properties
US5006513A (en) 1987-11-09 1991-04-09 Miles Inc. Antimycotic compositions of nikkomycin compounds and azole antimycotica
CA1331757C (en) 1988-02-29 1994-08-30 Janssen Pharmaceutica Naamloze Vennootschap 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
ES2159623T3 (es) * 1993-12-21 2001-10-16 Schering Corp Antifungicos de tetrahidrofurano.
CA2197672C (en) 1995-06-02 2011-05-17 Anil K. Saksena Tetrahydrofuran antifungals
AU6257396A (en) * 1995-06-19 1997-01-15 Schering Corporation Tetrahydrofuran antifungals
EP0862463A1 (de) 1995-11-23 1998-09-09 Janssen Pharmaceutica N.V. Feste mischungen von cyclodextrinen, hergestellt durch schmelzextrusionsverfahren
US6262052B1 (en) 1997-02-11 2001-07-17 Janssen Pharmaceutica N.V. Amino acid ester containing azole antifungals
JPH10231296A (ja) * 1997-02-19 1998-09-02 Schering Plough Corp テトラヒドロフラン抗真菌剤
US5883097A (en) * 1998-04-16 1999-03-16 Schering Corporation Soluble azole antifungal salt

Also Published As

Publication number Publication date
BR0010279A (pt) 2002-05-14
JP4610744B2 (ja) 2011-01-12
DE60001734T2 (de) 2004-02-05
HUP0200872A2 (hu) 2002-12-28
EP1177192B1 (de) 2003-03-19
ZA200109045B (en) 2003-02-03
SK15772001A3 (sk) 2002-12-03
NO20015372D0 (no) 2001-11-02
MXPA01011117A (es) 2002-06-04
WO2000066580A3 (en) 2001-04-05
ES2194723T3 (es) 2003-12-01
CA2372691A1 (en) 2000-11-09
WO2000066580A2 (en) 2000-11-09
HUP0200872A3 (en) 2003-04-28
CN1349540A (zh) 2002-05-15
JP2002543196A (ja) 2002-12-17
ID30409A (id) 2001-11-29
ATE234833T1 (de) 2003-04-15
DE60001734D1 (de) 2003-04-24
CZ20013866A3 (cs) 2002-06-12
EA200101172A1 (ru) 2002-04-25
HRP20010763A2 (en) 2002-10-31
IL146302A0 (en) 2002-07-25
US6583136B1 (en) 2003-06-24
AU4557100A (en) 2000-11-17
PL351749A1 (en) 2003-06-16
CA2372691C (en) 2009-11-17
AU768491B2 (en) 2003-12-11
TR200103212T2 (tr) 2002-04-22
NZ515118A (en) 2003-04-29
NO20015372L (no) 2001-11-02
BG105863A (bg) 2002-06-28
EP1177192A2 (de) 2002-02-06
KR20010094761A (ko) 2001-11-01

Similar Documents

Publication Publication Date Title
SE9904652D0 (sv) Novel Compounds
GEP20074148B (en) Pyrrolo-triazine aniline compounds useful as kinase inhibitors
NO303780B1 (no) Nye 4-arylpiperaziner og 4-arylpiperidiner, sammensetning inneholdende dem samt deres anvendelse til fremstilling av terapeutikum
EE200100350A (et) Fenüülfenantridiinid, nende kasutamine ravimite valmistamiseks ning neid sisaldav ravim
HUP0002104A2 (hu) Pirazolo[3,4-d]pirimidindion-származékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
HUP0300641A2 (hu) Triazaspiro[5.5]undekán-származékok és hatóanyagként ezeket tartalmazó gyógyszerkészítmények
HUP0401488A2 (hu) Fungicid hatású 7-amino-triazolopirimidinek, előállításuk, alkalmazásuk és ilyeneket tartalmazó készítmények
NO20050666L (no) 2,7-substituerte indoler og deres anvendelse som 5-HT6 modulatorer
NO20050088L (no) Kationisk substituerte difenylazefidinoner, fremgangsmate for deres fremstilling, medikamenter inneholdende nevnte forbindelser og anvendelse derav
CA2331187A1 (en) Water soluble azoles as broad-spectrum antifungals
CL2021001299A1 (es) Compuestos meta-diamida para controlar plagas de invertebrados
ES482700A1 (es) Procedimiento para la obtencion de alfa-azolil-beta-hidroxi-cetonas.
ATE294793T1 (de) Phenantrhridin-n-oxides mit pde-iv hemmender wirkung
EE200100575A (et) Seentevastased eetrid, nende valmistamismeetod jakasutamine, kompositsioon ja selle valmistamismeetod
ATE315029T1 (de) 6-arylphenanthridine mit pde-iv hemmender wirkung
ES8307260A1 (es) Procedimiento para la obtencion de derivados de trifluormetil-fenoxifenil-silicio.
AU2002221737A1 (en) Antifungal 4-substituted 5,6-dihydro-4h-pyrrolo(1,2-a)(1,4)benzodiazepines
DK266686D0 (da) 1-aryl-5-alkoximinoalkylaminopyrazoler, fremgangsmaader til fremstilling deraf og deres anvendelse som herbicider og vaekstregulatorer
ES8200669A1 (es) Un procedimiento para la preparacion de nuevos compuestos iminicos heterociclicos
EP0407594A4 (en) Novel tetrahydropyrimidine derivatives, process for their preparation and insecticides containing same as active ingredients
TW429147B (en) Pharmaceutical composition for the treatment of CNS disorders
BG103103A (en) 1-isothiazolidinon derivatives of azetidin-2-on, methods for their preparation and application
SE0000477D0 (sv) Novel compounds
SE9904677D0 (sv) Novel compounds
ES8200087A1 (es) Procedimiento para la preparacion de sulfonil- o sulfinila- cetanilidas fungicidas